Companies: 10,795·Total market cap: $144.5T
Beta Bionics, Inc.

Beta Bionics, Inc.

BBNXNASDAQHealthcare● Active
$13.96
+$0.07(+0.47%)
Market Cap$621858454
P/E Ratio
52W High$32.71
52W Low$8.8
Overview

Beta Bionics, Inc. (BBNX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

bbnx · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 8 Wall Street analysts in the past 3 months

SellBuy

Buy

8 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
2
Sell
0
Strong Sell
0
Total: 8 · Buy rate: 75.0%

12-Month Price Target

High

$25.00

Consensus

$19.86

+39.3% upside

Low

$14.00

Median: $20 · Last Close: $14.26

The Beta Bionics, Inc. (BBNX) analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month BBNX price target is $19.86, representing +39.3% upside from the current price of $14.26.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $20 (39.3%)

Consensus Target

$19.86

39.3% upside

High Target

$25

75.4%

Low Target

$14

-1.8%

Current Price

$14.26

as of today

Based on analyst price targets, the BBNX stock price prediction for the next 12 months ranges from $14 to $25. The consensus BBNX price forecast of $19.86 implies 39.3% upside from the current price of $14.26.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$14.975.00%

1-day model range: $14.84–$15.09. Peak: $15.09 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$8-45.2%
2028$6-58.9%
2029$5-64.5%
2030$5-67.2%
2031-68.5%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

79%0%21%
11Buy
0Neutral
3Sell
RSI (14)90.9Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · BBNX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$13.45BUY
MA 10$12.76BUY
MA 20$11.35BUY
MA 50$10.96BUY
MA 100$12.11BUY
MA 200$18.63SELL
Current $BBNX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$13.56BUY
EMA 10$12.84BUY
EMA 20$12.01BUY
EMA 50$11.74BUY
EMA 100$13.41BUY
EMA 200$15.32SELL
Current $BBNX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Goldman Sachs2026-05-27
Maintains
BuyBuy
B of A Securities2026-05-18
Maintains
NeutralNeutral
Stifel2026-04-22
Maintains
BuyBuy
Leerink Partners2026-04-22
Maintains
OutperformOutperform
Truist Securities2026-04-15
Maintains
BuyBuy
Goldman Sachs2026-04-09
Maintains
BuyBuy
Baird2026-02-18
Maintains
NeutralNeutral
Stifel2026-02-18
Maintains
BuyBuy
Stifel2026-02-04
Maintains
BuyBuy
Truist Securities2026-02-02
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Beta Bionics, Inc. (BBNX) stock. Of the recent 21 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover BBNX.

Analyst Recommendation Trends

Buy ratings514
Hold ratings01↑ +1
Sell ratings00

BBNX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$134M

↓ 47.0% YoY

Revenue Next Year

$181M

↑ 35.2% YoY

EPS This Year

$-2.16

EPS Next Year

$-2.11

↓ 2.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BBNX EPS of $-2.16 for the current fiscal year, based on estimates from 6 analysts. The BBNX revenue forecast is $134M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BBNX stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BBNX price target is $19.86 (+39.3% upside), with an analyst consensus of Buy.

The BBNX short-term stock prediction for tomorrow is $14.97 (+5.00%). The BBNX stock price prediction for 2027 estimates an average of $8. The BBNX stock prediction for 2030 projects a range of $4–$5.

Beta Bionics, Inc. trades on NASDAQ under the ticker BBNX. The BBNX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BBNX forecast · 8 questions

According to 8 Wall Street analysts, the average 12-month BBNX price target is $19.86, with a high forecast of $25.00 and a low of $14.00. The median price target is shown in the chart above when available. This implies +39.3% potential upside from the current price of $14.26.

BBNX price targetWhat is BBNX price targetBBNX analyst price targetBBNX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.